Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield

Ian S. Wedmore, Russ S. Kotwal, John G. McManus, Andre M Pennardt, Timothy S. Talbot, Marcie Fowler, Laura McGhee

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

BACKGROUND: Acute pain, resulting from trauma and other causes, is a common condition that imposes a need for prehospital analgesia on and off the battlefield. The narcotic most frequently used for prehospital analgesia on the battlefield during the past century has been morphine. Intramuscular morphine has a delayed onset of pain relief that is suboptimal and difficult to titrate. Although intravenously administered morphine can readily provide rapid and effective prehospital analgesia, oral transmucosal fentanyl citrate (OTFC) is a safe alternative that does not require intravenous access. This study evaluates the safety and efficacy of OTFC in the prehospital battlefield environment. METHODS: Data collected during combat deployments (Afghanistan and Iraq) from March 15, 2003, to March 31, 2010, were analyzed. Patients were US Army Special Operations Command casualties. Patients receiving OTFC for acute pain were evaluated. Pretreatment and posttreatment pain intensities were quantified by the verbal numeric rating scale (NRS) from 0 to 10. OTFC adverse effects and injuries treated were also evaluated. RESULTS: A total of 286 patients were administered OTFC, of whom 197 had NRS pain evaluations conducted before and approximately 15 minutes to 30 minutes following treatment. The difference between NRS pain scores at 0 minutes (NRS, 8.0 [1.4]) and 15 minutes to 30 minutes (NRS, 3.2 [2.1]) was significant (p < 0.001). Only 18.3% (36 of 197) of patients were also administered other types of analgesics. Nausea was the most common adverse effect as reported by 12.7% (25 of 197) of patients. The only major adverse effect occurred in the patient who received the largest opioid dose, 3,200-μg OTFC and 20-mg morphine. This patient exhibited hypoventilation and saturation of less than 90% requiring low-dose naloxone. CONCLUSION: OTFC is a rapid and noninvasive pain management strategy that provides safe and effective analgesia in the prehospital battlefield setting. OTFC has considerable implications for use in civilian prehospital and austere environments. LEVEL OF EVIDENCE: Therapeutic study, level IV.

Original languageEnglish (US)
JournalJournal of Trauma and Acute Care Surgery
Volume73
Issue number6 SUPPL. 5
DOIs
StatePublished - Dec 1 2012
Externally publishedYes

Fingerprint

Fentanyl
Safety
Pain
Analgesia
Morphine
Acute Pain
Afghanistan
Hypoventilation
Iraq
Narcotics
Wounds and Injuries
Pain Management
Naloxone
Nausea
Opioid Analgesics
Analgesics
Therapeutics

Keywords

  • Acute pain
  • battlefield
  • oral transmucosal fentanyl citrate
  • pain management
  • prehospital analgesia

ASJC Scopus subject areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Cite this

Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield. / Wedmore, Ian S.; Kotwal, Russ S.; McManus, John G.; Pennardt, Andre M; Talbot, Timothy S.; Fowler, Marcie; McGhee, Laura.

In: Journal of Trauma and Acute Care Surgery, Vol. 73, No. 6 SUPPL. 5, 01.12.2012.

Research output: Contribution to journalArticle

Wedmore, Ian S. ; Kotwal, Russ S. ; McManus, John G. ; Pennardt, Andre M ; Talbot, Timothy S. ; Fowler, Marcie ; McGhee, Laura. / Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield. In: Journal of Trauma and Acute Care Surgery. 2012 ; Vol. 73, No. 6 SUPPL. 5.
@article{727a69ca7b3f4a2ebb3a9dd4a9ffaa15,
title = "Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield",
abstract = "BACKGROUND: Acute pain, resulting from trauma and other causes, is a common condition that imposes a need for prehospital analgesia on and off the battlefield. The narcotic most frequently used for prehospital analgesia on the battlefield during the past century has been morphine. Intramuscular morphine has a delayed onset of pain relief that is suboptimal and difficult to titrate. Although intravenously administered morphine can readily provide rapid and effective prehospital analgesia, oral transmucosal fentanyl citrate (OTFC) is a safe alternative that does not require intravenous access. This study evaluates the safety and efficacy of OTFC in the prehospital battlefield environment. METHODS: Data collected during combat deployments (Afghanistan and Iraq) from March 15, 2003, to March 31, 2010, were analyzed. Patients were US Army Special Operations Command casualties. Patients receiving OTFC for acute pain were evaluated. Pretreatment and posttreatment pain intensities were quantified by the verbal numeric rating scale (NRS) from 0 to 10. OTFC adverse effects and injuries treated were also evaluated. RESULTS: A total of 286 patients were administered OTFC, of whom 197 had NRS pain evaluations conducted before and approximately 15 minutes to 30 minutes following treatment. The difference between NRS pain scores at 0 minutes (NRS, 8.0 [1.4]) and 15 minutes to 30 minutes (NRS, 3.2 [2.1]) was significant (p < 0.001). Only 18.3{\%} (36 of 197) of patients were also administered other types of analgesics. Nausea was the most common adverse effect as reported by 12.7{\%} (25 of 197) of patients. The only major adverse effect occurred in the patient who received the largest opioid dose, 3,200-μg OTFC and 20-mg morphine. This patient exhibited hypoventilation and saturation of less than 90{\%} requiring low-dose naloxone. CONCLUSION: OTFC is a rapid and noninvasive pain management strategy that provides safe and effective analgesia in the prehospital battlefield setting. OTFC has considerable implications for use in civilian prehospital and austere environments. LEVEL OF EVIDENCE: Therapeutic study, level IV.",
keywords = "Acute pain, battlefield, oral transmucosal fentanyl citrate, pain management, prehospital analgesia",
author = "Wedmore, {Ian S.} and Kotwal, {Russ S.} and McManus, {John G.} and Pennardt, {Andre M} and Talbot, {Timothy S.} and Marcie Fowler and Laura McGhee",
year = "2012",
month = "12",
day = "1",
doi = "10.1097/TA.0b013e3182754674",
language = "English (US)",
volume = "73",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "6 SUPPL. 5",

}

TY - JOUR

T1 - Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield

AU - Wedmore, Ian S.

AU - Kotwal, Russ S.

AU - McManus, John G.

AU - Pennardt, Andre M

AU - Talbot, Timothy S.

AU - Fowler, Marcie

AU - McGhee, Laura

PY - 2012/12/1

Y1 - 2012/12/1

N2 - BACKGROUND: Acute pain, resulting from trauma and other causes, is a common condition that imposes a need for prehospital analgesia on and off the battlefield. The narcotic most frequently used for prehospital analgesia on the battlefield during the past century has been morphine. Intramuscular morphine has a delayed onset of pain relief that is suboptimal and difficult to titrate. Although intravenously administered morphine can readily provide rapid and effective prehospital analgesia, oral transmucosal fentanyl citrate (OTFC) is a safe alternative that does not require intravenous access. This study evaluates the safety and efficacy of OTFC in the prehospital battlefield environment. METHODS: Data collected during combat deployments (Afghanistan and Iraq) from March 15, 2003, to March 31, 2010, were analyzed. Patients were US Army Special Operations Command casualties. Patients receiving OTFC for acute pain were evaluated. Pretreatment and posttreatment pain intensities were quantified by the verbal numeric rating scale (NRS) from 0 to 10. OTFC adverse effects and injuries treated were also evaluated. RESULTS: A total of 286 patients were administered OTFC, of whom 197 had NRS pain evaluations conducted before and approximately 15 minutes to 30 minutes following treatment. The difference between NRS pain scores at 0 minutes (NRS, 8.0 [1.4]) and 15 minutes to 30 minutes (NRS, 3.2 [2.1]) was significant (p < 0.001). Only 18.3% (36 of 197) of patients were also administered other types of analgesics. Nausea was the most common adverse effect as reported by 12.7% (25 of 197) of patients. The only major adverse effect occurred in the patient who received the largest opioid dose, 3,200-μg OTFC and 20-mg morphine. This patient exhibited hypoventilation and saturation of less than 90% requiring low-dose naloxone. CONCLUSION: OTFC is a rapid and noninvasive pain management strategy that provides safe and effective analgesia in the prehospital battlefield setting. OTFC has considerable implications for use in civilian prehospital and austere environments. LEVEL OF EVIDENCE: Therapeutic study, level IV.

AB - BACKGROUND: Acute pain, resulting from trauma and other causes, is a common condition that imposes a need for prehospital analgesia on and off the battlefield. The narcotic most frequently used for prehospital analgesia on the battlefield during the past century has been morphine. Intramuscular morphine has a delayed onset of pain relief that is suboptimal and difficult to titrate. Although intravenously administered morphine can readily provide rapid and effective prehospital analgesia, oral transmucosal fentanyl citrate (OTFC) is a safe alternative that does not require intravenous access. This study evaluates the safety and efficacy of OTFC in the prehospital battlefield environment. METHODS: Data collected during combat deployments (Afghanistan and Iraq) from March 15, 2003, to March 31, 2010, were analyzed. Patients were US Army Special Operations Command casualties. Patients receiving OTFC for acute pain were evaluated. Pretreatment and posttreatment pain intensities were quantified by the verbal numeric rating scale (NRS) from 0 to 10. OTFC adverse effects and injuries treated were also evaluated. RESULTS: A total of 286 patients were administered OTFC, of whom 197 had NRS pain evaluations conducted before and approximately 15 minutes to 30 minutes following treatment. The difference between NRS pain scores at 0 minutes (NRS, 8.0 [1.4]) and 15 minutes to 30 minutes (NRS, 3.2 [2.1]) was significant (p < 0.001). Only 18.3% (36 of 197) of patients were also administered other types of analgesics. Nausea was the most common adverse effect as reported by 12.7% (25 of 197) of patients. The only major adverse effect occurred in the patient who received the largest opioid dose, 3,200-μg OTFC and 20-mg morphine. This patient exhibited hypoventilation and saturation of less than 90% requiring low-dose naloxone. CONCLUSION: OTFC is a rapid and noninvasive pain management strategy that provides safe and effective analgesia in the prehospital battlefield setting. OTFC has considerable implications for use in civilian prehospital and austere environments. LEVEL OF EVIDENCE: Therapeutic study, level IV.

KW - Acute pain

KW - battlefield

KW - oral transmucosal fentanyl citrate

KW - pain management

KW - prehospital analgesia

UR - http://www.scopus.com/inward/record.url?scp=84871199554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871199554&partnerID=8YFLogxK

U2 - 10.1097/TA.0b013e3182754674

DO - 10.1097/TA.0b013e3182754674

M3 - Article

VL - 73

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 6 SUPPL. 5

ER -